Aimei Health Technology Co., Ltd. has filed a current report indicating the issuance of a promissory note to fund an extension of its deadline to complete a business combination. The company deposited an aggregate of $34,330.96 into a trust account to extend the termination date of its initial business combination by one month.
The extension, which is the twenty-third permitted under the company's Amended and Restated Articles of Association, moves the termination date from October 6, 2026, to November 6, 2026. The extension payment represents the lesser of $80,000 for all outstanding public shares or $0.033 for each outstanding public share.
To fund this payment, Aimei Health issued an unsecured promissory note dated October 5, 2026, to Aimei Investment Ltd. The note has a principal amount of $34,330.96 and does not bear interest. The principal is due upon the consummation of a business combination with United Hydrogen.
The payee, Aimei Investment Ltd, holds the right to convert the promissory note into private units of the company. The conversion option allows the holder to exchange the note for private units at a price of $10.00 per unit. Each private unit consists of one ordinary share and one right to receive one-fifth of one ordinary share. The conversion must be exercised by providing written notice at least two business days prior to the closing of the business combination.
